ZURICH (Reuters) – Novartis has released data showing sharply improved overall survival rates for its breast cancer drug Kisqali, which the Swiss drugmaker hopes will help it chip away at the dominance of Pfizer’s blockbuster Ibrance. FILE PHOTO: The logo of Swiss drugmaker Novartis is seen at its headquarters in Basel, Jan. 25, 2017. REUTERS/Arnd… Read More »
Analyzing data may be the main job of data scientists, but keeping it secure and private is not far behind. This is not easy—data is more complex and shared more widely than ever before, making it exponentially more vulnerable to today’s latest threats. Of course, this is a significant concern for healthcare organizations and other… Read More »
In an effort it says will help hospitals and health plans to better aggregate data from disparate electronic health records after mergers, Wolters Kluwer has developed new technology that uses machine learning to improve the process mapping lab results and other data to standardized LOINC codes. WHY IT MATTERSMapping lab results to LOINC manually can… Read More »